This was a busy fall for Norton Lab! We received an NIH RO1 grant for testing the efficacy of new generation proteins, LTA and LTA1, as adjuvants. We were also in the midst of a clinical study in partnership with the LA CaTS Clinical Translational Unit (CTU) to see how well the flu vaccine was working the New Orleans community. In our LA CaTS study, we were particularly interested in how factors linked to increased inflammation – age, diabetes, HIV, diet, exercise – correlated with vaccine response. Below are links some of the media coverage we’ve received for these two projects.
“Tulane seeks volunteers in fight to improve flu vaccines” – November 4, 2015, by Rob Masson, Fox8 WVUE
“Researchers at Tulane seeking better ways to fight the flu” – November 01, 2015 by Della Hasselle, The New Orleans Advocate
“Tulane doctor hopes to make medical history with $1.6 million” – October 28, 2015, by Stephanie Oswald, WGNO ABC
“Tulane gets $1.6 million to develop better flu vaccine” – October 26, 2015, by Caroline Scofield, Tulane New Wave